The intravenous injection of prostaglandin E 1 (PGE 1 ) causes a dose-dependent relaxation of the lower esophageal sphincter (LES) in the intact, lightly anesthetized opossum. The action of PGE 1 is not inhibited by the drugs that produce muscarinic or nicotinic cholinergic antagonism or alpha and beta adrenergic antagonism in the doses that inhibited the action of respective agonists. Moreover, this action is not affected by exogenous gastrin pentapeptide. The action of PGE 1 on the LES is mimicked by isoproterenol, theophylline ethylenediamine, and dibutyryl cyclic AMP. Both theophylline, a phosphodiesterase inhibitor, and isoproterenol, an adenyl cyclase stimulator, added to the action of PGE 1 . On the other hand, adenyl cyclase inhibitor nicotinic acid, as well as phosphodiesterase stimulator, imidazole inhibited its action. Further, both nicotinic acid and imidazole inhibited the degree of LES relaxation produced by esophageal distension. These studies suggest that intracellular cyclic AMP may act as the "second messenger" in the regulation of the lower esophageal sphincter relaxation.
A B S T R A C T The intravenous injection of prostaglandin E1 (PGE1) causes a dose-dependent relaxation of the lower esophageal sphincter (LES) in the intact, lightly anesthetized opossum. The action of PGE1 is not inhibited by the drugs that produce muscarinic or nicotinic cholinergic antagonism or alpha and beta adrenergic antagonism in the doses that inhibited the action of respective agonists. Moreover, this action is not affected by exogenous gastrin pentapeptide. The action of PGE1 on the LES is mimicked by isoproterenol, theophylline ethylenediamine, and dibutyryl cyclic AMP. Both theophylline, a phosphodiesterase inhibitor, and isoproterenol, an adenyl cyclase stimulator, added to the action of PGE1. On the other hand, adenyl cyclase inhibitor nicotinic acid, as well as phosphodiesterase stimulator, imidazole inhibited its action. Further, both nicotinic acid and imidazole inhibited the degree of LES relaxation produced by esophageal distension. These studies suggest that intracellular cyclic AMP may act as the "second messenger" in the regulation of the lower esophageal sphincter relaxation.
INTRODUCTION
The lower esophageal sphincter (LES)' relaxes in response to swallowing to allow the passage of an ingested bolus of food (1) , but the mechanism of this relaxation is not well understood. We have found that prostaglandin E1 (2) and theophylline are potent relaxants of the LES. Beta adrenergic stimulation has previously been reported to cause inhibition of the circular muscle Received for publication 14 July 1972 and in revised form 30 October 1972.
'Abbreviations and trivial namnes used in this paper: cAMP, cyclic AMP; hexamethonium, hexamethylenebis (trimethylammonium chloride); isoproterenol, di-fi- (3,4-di- hydroxyphenyl) -a-isopropylamino ethanol; LES, lower esophageal sphincter; phentolamine, 2-(N-(m-hydroxyphenyl)-p-toluidinomethyl) imidazoline; propranolol, 1-(isopropylamino) -3-(1-naphthyloxy) -2-propanol hydrochloride; PGE,, prostaglandin E1; theophylline, 1-3-dimethylxanthine.
from the lower esophagus (3) including the sphincteric zone (4) . Prostaglandins of E type, theophylline and isoproterenol, have been shown to enhance cyclic AMP in many tissues (5) . We present here indirect evidence in an in vivo system which suggests that PGEi, theophylline, and isoproterenol may produce LES relaxation by enhancing cyclic AMP in the lower esophageal sphincter.
METHODS
Studies were done in the opossum (Didelphis virginiana) because the lower part of the esophagus and the lower esophageal sphincter, like that of man, is composed of smooth muscle fibers (6) . The animals weighed between 2 and 3.5 kg and were of either sex. The animals were anesthetized with intraperitoneal sodium pentobarbital, 50 mg/kg, and were strapped supine to the animal board. The LES pressure was continuously monitored with a waterfilled polyvinyl catheter. An assembly of three polyvinyl catheters (ID = 0.86 mm and OD = 1.17 mm) glued together with tetrahydrofuran, and each with side opening 1 cm apart, was connected to three pressure transducers. The catheters were constantly perfused with bubble-free water at a rate of 4.6 ml/h with a constant infusion pump (Harvard Apparatus Co., Inc., Millis, Mass.). The catheter assembly was introduced through the animal's mouth so that all the openings recorded intragastric pressures. The assembly was then gradually withdrawn so that the proximal opening was in the body of the esophagus, the middle one recorded the highest pressure in the lower high pressure zone and the distal one measured intragastric pressures.
In initial studies a catheter assembly with openings I cm apart was used in order to evaluate the possibility of the movement of the LES in relation to recording opening. Movement of the catheter assembly would shift the high pressure zone in either the proximal or the distal lead.
LES relaxation produced by PGE, and other agents could not be related to such a shift in the high pressure zone.
Test substances were injected through an intravenous cannula as a single bolus or by a slow continuous infusion. In some experiments, dibutyryl cyclic AMP and acetylcholine were injected directly into the left gastric artery which supplies the lower esophagus through its esophageal branch ( noted. To make the data uniform, change in sphincter pressure was expressed as a percent of the resting base line pressure just before the injection of the drug.
To study the effect of the agents in modifying the action of PGE, the test agents were first injected and when the peak action had been reached, PGE1 ( 1 ,ug/kg) was injected. 
RESULTS
The reproducibility of the changes in the LES pressure in response to test agents was good. The mean coefficient of variation was 6.5% in the same animal and 6.3% in different animals, calculated for PGE1 in the dose of 1 /Ag/kg.
Effect of prostaglandin El. Fig. 2 shows a representative response to a single intravenous injection of PGE1. Injection of 0.19% ethanol (vehicle for PGE1) produced no effect. The effect of PGE1 was dose-dependent (Table I ). The action, on an average, started in a minute after injection. The maximal action occurred with a dose of 2 lAg/kg. The duration of action varied from 1-17 min and was also dose related (Table I) .
Prostaglandins of E type cause a fall in arterial blood pressure. In four experiments the direct carotid blood pressure fell after PGEi (1 /g/kg) administration by 37-50 mm Hg systolic and 24-47 mm Hg diastolic. This hypotension alone was not responsible for the fall in LES pressure; a comparable degree of hypotension produced by blood letting in seven animals produced no significant change in LES pressure.2 2Goyal, R. K., and S. Rattan. Unpublished data. Effect of neural antagonists. Information on the effect of different neural antagonists on the LES in the opossum in vivo was obtained. Alpha adrenergic antagonist phentolamine and muscarinic antagonist atropine caused a fall in sphincter pressure whereas beta adrenergic antagonist propranolol and nicotinic antagonist hexamethonium caused an increase (Table II) .
Influence of the neural antagonists in modifying the action of PGE,. Effect of isoproterenol, theophylline, and dibutyryl cyclic AMP. The effect of isoproterenol and theophylline was tested because they are known to enhance cAMP levels in many tissues; isoproterenol acts by adenyl cyclase stimulation and theophylline by inhibiting phosphodiesterase (5). Both these agents produced a dose-dependent fall in the LES pressure (Fig. 3) . Ethylenediamine, the vehicle for theophylline, caused no change in sphincter pressure. Dibutyryl cyclic AMP, a lipid soluble analogue of cAMP, when given intravenously had no effect on the sphincter pressure up to a dose of 15 mg/kg. However, upon injection directly into the arterial supply of the LES from the left gastric artery, it produced a dose-dependent fall in LES pressure; the mean ±SE percent fall in LES pressure was Fig. 4 , nicotinic acid, an inhibitor of adenyl cyclase (7) inhibited the action of PGE1 in a dose that did not alter the sphincter pressure. Imidazole, a stimulator of phosphodiesterase (8) (5) . We investigated the effects of some unrelated agents that also act to cause increase in cAMP levels such as isoproterenol and theophylline; they both produced dose-dependent relaxation of the LES. Moreover, dibutyryl cyclic AMP also produced similar effect. These evidences are further supported by (a) additive response to the action of PGEi by isoproterenol and theophylline and (b) inhibition of PGE, action by nicotinic acid and imidazole which inhibit cAMP synthesis and enhance cAMP breakdown, respectively. Furthermore, cyclic AMP related relaxation has been shown to occur in other smooth muscles of the body. Triner et al. (9) have shown that increase in the levels of cAMP caused by different agents produces relaxation of the smooth muscle from the rat uterus and arteries in vitro; the biochemical and functional effects were found to be dose-dependent and quantitatively correlated. The body of the esophagus showed no change in response to these agents. This may be due to the fact that in the absence of background resting pressure, inhibition of activity is difficult to evaluate. Bennett and Fleshler (10) have recently reviewed the actions of prostaglandins on the gastrointestinal tract. PGE1 was found to cause relaxation of the circular muscles of the different organs. Our study suggests that the inhibition of the sphincter pressure may be an active, closely controlled and graded process although withdrawal of the action of excitatory agents such as gastrin may also lead to inhibition of the sphincter pressure (11) .
The inhibition of the physiologically induced relaxation of the LES in our studies with agents which inhibit tissue cyclic AMP indicates that cyclic AMP mechanism may also be involved in the sphincter relaxation under physiological conditions.
The neurohormonal pathway responsible for LES relaxation is not well understood. There is some evidence to suggest that certain inhibitory nerves may be involved in the inhibition of gut muscle (12) including the LES (13). Burnstock, Campbell, Satchell, and Smythe (12) have suggested that adenosine triphosphate or a related nucleotide may be a neurotransmitter of these inhibitory nerves. ATP has been known to cause relaxation of the smooth muscles (12, 14) . It is of interest because ATP is substrate for adenyl cyclase and this agent has been shown to inhibit phosphodiesterase (15) 
